GamaMabs Pharma Competitors and Similar CompaniesClear all
Seagen's competitors and similar companies include Mersana Therapeutics.
 Seagen Seagen (formerly known as Seattle Genetics) is a biotechnology company that develops and commercializes targeted therapies to treat cancer. |  Mersana Therapeutics Mersana Therapeutics is a clinical-stage biotechnology company developing antibody-drug conjugate (ADC) platforms. | |
Founding Date | Founding Date 1998 | Founding Date 2005 |
Type | Type Subsidiary | Type Public |
Tags | ||
Locations | Locations Bothell, US HQ Mississauga, CA Hørsholm, DK Rueil Malmaison, FR München, DE Milano, IT Schiphol, NL see more | Locations Cambridge, US HQ |
Employees | Employees 3,25622% increase | Employees 11033% increase |
Financial | ||
Revenue (est.) | Revenue (est.) $2b (FY, 2022) | Revenue (est.) $40.5m (FY, 2024) |
Net income | Net income ($610.3m) (FY, 2022) | Net income ($69.2m) (FY, 2024) |
Funding | ||
Total funding raised | Total funding raised $ 164m | Total funding raised $ 219.5m |
For sources of this data, please see the company profile
View Company Profiles
Mersana Therapeutics
HQ
Cambridge, US
Employees
110↑ 33% increase
Mersana Therapeutics is a clinical-stage biotechnology company developing antibody-drug conjugate (ADC) platforms.
View company